AbbVie (ABBV) Short Interest Ratio & Short Volume

Short interest is the volume of AbbVie shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 13,540,000 shares of ABBV short. Learn More on AbbVie's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ABBV shares currently have a short interest ratio of 2.0. Learn More on AbbVie's short interest ratio.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of AbbVie: Oak Hill Wealth Advisors LLC, Simplex Trading LLC, Wealth Enhancement Advisory Services LLC, Clarity Financial LLC, Portman Square Capital LLP, Curated Wealth Partners LLC, Nomura Holdings Inc., Readystate Asset Management LP, Parallax Volatility Advisers L.P., HAP Trading LLC, BlueCrest Capital Management Ltd, Citadel Advisors LLC, Clear Street Markets LLC, Royal Bank of Canada, Cubist Systematic Strategies LLC, Nomura Holdings Inc., Capital Fund Management S.A., Eisler Capital US LLC, Eisler Capital UK Ltd., Kopernik Global Investors LLC, Capstone Investment Advisors LLC, Allianz Asset Management GmbH, Hsbc Holdings PLC, Mendel Money Management, US Bancorp DE, IMC Chicago LLC, Wells Fargo & Company MN, UBS Group AG, BNP Paribas Financial Markets, Gladius Capital Management LP, Concourse Financial Group Securities Inc., Simplex Trading LLC, XR Securities LLC, Wolverine Asset Management LLC, and SpiderRock Advisors LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

AbbVie saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 13,540,000 shares, an increase of 3.2% from the previous total of 13,120,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the sector of "medical" compare to AbbVie: Merck & Co., Inc. (0.81%), Johnson & Johnson (0.69%), Pfizer Inc. (1.20%), Bristol-Myers Squibb (1.69%), IQVIA Holdings Inc. (1.58%), Seagen Inc. (5.10%), Moderna, Inc. (6.24%), IDEXX Laboratories, Inc. (2.08%), BioNTech SE (1.33%), Illumina, Inc. (3.31%),

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks.

Short selling ABBV is an investing strategy that aims to generate trading profit from AbbVie as its price is falling. ABBV shares are trading down $7.54 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for AbbVie occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ABBV, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ABBV, twice per month. The most recent reporting period available is April, 15 2024.